The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Rhinovirus Infection Induces Degradation of Antimicrobial Peptides and Secondary Bacterial Infection in Chronic Obstructive Pulmonary Disease
Open accessAbstract
RATIONALE: Chronic obstructive pulmonary disease (COPD) exacerbations are associated with virus (mostly rhinovirus) and bacterial infections, but it is not known whether rhinovirus infections precipitate secondary bacterial infections. OBJECTIVES: To investigate relationships between rhinovirus infection and bacterial infection and the role of antimicrobial peptides in COPD exacerbations. METHODS: We infected subjects with moderate COPD and smokers and nonsmokers with normal lung function with rhinovirus. Induced sputum was collected before and repeatedly after rhinovirus infection and virus and bacterial loads measured with quantitative polymerase chain reaction and culture. The antimicrobial peptides secretory leukoprotease inhibitor (SLPI), elafin, pentraxin, LL-37, α-defensins and β-defensin-2, and the protease neutrophil elastase were measured in sputum supernatants. MEASUREMENTS AND MAIN RESULTS: After rhinovirus infection, secondary bacterial infection was detected in 60% of subjects with COPD, 9.5% of smokers, and 10% of nonsmokers (P < 0.001). Sputum virus load peaked on Days 5-9 and bacterial load on Day 15. Sputum neutrophil elastase was significantly increased and SLPI and elafin significantly reduced after rhinovirus infection exclusively in subjects with COPD with secondary bacterial infections, and SLPI and elafin levels correlated inversely with bacterial load. CONCLUSIONS: Rhinovirus infections are frequently followed by secondary bacterial infections in COPD and cleavage of the antimicrobial peptides SLPI and elafin by virus-induced neutrophil elastase may precipitate these secondary bacterial infections. Therapy targeting neutrophil elastase or enhancing innate immunity may be useful novel therapies for prevention of secondary bacterial infections in virus-induced COPD exacerbations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Self-citationZhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2015) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,533
Projections of Global Mortality and Burden of Disease from 2002 to 2030
Mathers, C. D., & Loncar, D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030442 · Cited by 11,386
PAUWELS, R. A., BUIST, A. S., CALVERLEY, P. M. A., JENKINS, C. R., & HURD, S. S. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.5.2101039 · Cited by 6,587
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
Hurst, J. R., Vestbo, J., Anzueto, A., Locantore, N., Müllerova, H., Tal-Singer, R., Miller, B., Lomas, D. A., Agusti, A., MacNee, W., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909883 · Cited by 2,981
Effect of Exacerbation on Quality of Life in Patients with Chronic Obstructive Pulmonary Disease
SEEMUNGAL, T. A. R., DONALDSON, G. C., PAUL, E. A., BESTALL, J. C., JEFFRIES, D. J., & WEDZICHA, J. A. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.5.9709032 · Cited by 2,312
Donaldson, G. C. (2002) · Thorax · doi:10.1136/thorax.57.10.847 · Cited by 2,272
Disordered Microbial Communities in Asthmatic Airways
Hilty, M., Burke, C., Pedro, H., Cardenas, P., Bush, A., Bossley, C., Davies, J., Ervine, A., Poulter, L., Pachter, L., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008578 · Cited by 1,824
Bafadhel, M., McKenna, S., Terry, S., Mistry, V., Reid, C., Haldar, P., McCormick, M., Haldar, K., Kebadze, T., Duvoix, A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201104-0597oc · Cited by 1,094
Self-citationInfections and Airway Inflammation in Chronic Obstructive Pulmonary Disease Severe Exacerbations
Papi, A., Bellettato, C. M., Braccioni, F., Romagnoli, M., Casolari, P., Caramori, G., Fabbri, L. M., & Johnston, S. L. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200506-859oc · Cited by 1,072 · cited 9×
“Quantitative bacterial culture was performed on induced sputum samples on blood agar, chocolate agar, CLED agar, and Sabouraud agar in the Microbiology Laboratory at Imperial College Healthcare NHS Trust (5).”
BackgroundMethodInfluentialSelf-citationSEEMUNGAL, T., HARPER-OWEN, R., BHOWMIK, A., MORIC, I., SANDERSON, G., MESSAGE, S., MacCALLUM, P., MEADE, T. W., JEFFRIES, D. J., JOHNSTON, S. L., et al. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.9.2105011 · Cited by 1,018
Self-citationAnalysis of the lung microbiome in the “healthy” smoker and in COPD.
Erb-Downward, J. R., Thompson, D. L., Han, M. K., Freeman, C. M., McCloskey, L., Schmidt, L. A., Young, V. B., Toews, G. B., Curtis, J. L., Sundaram, B., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016384 · Cited by 973 · cited 1×
“Because there is known to be a lower respiratory microbiome in health and disease (16, 17) and because antimicrobial peptides are known to be important in antibacterial host defense (18), we also hypothesized that secondary bacterial infections may be caused by perturbations in this host defense mechanism as a consequ…”
BackgroundChronic obstructive pulmonary disease
Decramer, M., Janssens, W., & Miravitlles, M. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60968-9 · Cited by 972
Message, S. D., Laza-Stanca, V., Mallia, P., Parker, H. L., Zhu, J., Kebadze, T., Contoli, M., Sanderson, G., Kon, O. M., Papi, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804181105 · Cited by 487
Self-citationMallia, P., Message, S. D., Gielen, V., Contoli, M., Gray, K., Kebadze, T., Aniscenko, J., Laza-Stanca, V., Edwards, M. R., Slater, L., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201006-0833oc · Cited by 415
Self-citationRhinovirus Disrupts the Barrier Function of Polarized Airway Epithelial Cells
Sajjan, U., Wang, Q., Zhao, Y., Gruenert, D. C., & Hershenson, M. B. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200801-136oc · Cited by 354
Predisposing factors to bacterial colonization in chronic obstructive pulmonary disease
Zalacain, R., Sobradillo, V., Amilibia, J., Barron, J., Achotegui, V., Pijoan, J. I., & Llorente, J. L. (1999) · European Respiratory Journal · doi:10.1034/j.1399-3003.1999.13b21.x · Cited by 210
Exacerbations of Chronic Obstructive Pulmonary Disease
Anzueto, A., Sethi, S., & Martinez, F. J. (2007) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200701-003fm · Cited by 200
Rhinovirus exposure impairs immune responses to bacterial products in human alveolar macrophages
Oliver, B. G. G., Lim, S., Wark, P., Laza-Stanca, V, King, N., Black, J. L., Burgess, J. K., Roth, M., & Johnston, S. L. (2008) · Thorax · doi:10.1136/thx.2007.081752 · Cited by 165
Self-citationSecretory Leukocyte Protease Inhibitor and Elafin/Trappin-2
Sallenave, J. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2010-0095rt · Cited by 155
Suppression of pulmonary innate host defence in smokers
Herr, C., Beißwenger, C., Hess, C., Kandler, K., Suttorp, N., Welte, T., Schroeder, J.-M., Vogelmeier, C. F., & R B. f. t. C. S. Group (2008) · Thorax · doi:10.1136/thx.2008.102681 · Cited by 149
Rhinovirus enhances various bacterial adhesions to nasal epithelial cells simultaneously
Wang, J. H., Kwon, H. J., & Jang, Y. J. (2009) · The Laryngoscope · doi:10.1002/lary.20498 · Cited by 136
Weldon, S., McNally, P., McElvaney, N. G., Elborn, J. S., McAuley, D. F., Wartelle, J., Belaaouaj, A., Levine, R. L., & Taggart, C. C. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901716 · Cited by 125
A community-based, time-matched, case-control study of respiratory viruses and exacerbations of COPD
Hutchinson, A. F., Ghimire, A., Thompson, M. A., Black, J., Brand, C. A., Lowe, A. J., Smallwood, D. M., Vlahos, R., Bozinovski, S., Brown, G. V., et al. (2007) · Respiratory Medicine · doi:10.1016/j.rmed.2007.07.015 · Cited by 106
Upper-Respiratory Viral Infection, Biomarkers, and COPD Exacerbations
Kherad, O., Kaiser, L., Bridevaux, P., Sarasin, F., Thomas, Y., Janssens, J.-P., & Rutschmann, O. (2010) · CHEST Journal · doi:10.1378/chest.09-2225 · Cited by 104
Mallia, P., Message, S. D., Kebadze, T., Parker, H. L., Kon, O. M., & Johnston, S. L. (2006) · Respiratory Research · doi:10.1186/1465-9921-7-116 · Cited by 97
Self-citationGuyot, N., Butler, M. W., McNally, P., Weldon, S., Greene, C. M., Levine, R. L., O'Neill, S. J., Taggart, C. C., & McElvaney, N. G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803707200 · Cited by 94
Virus infection in exacerbations of chronic obstructive pulmonary disease requiring ventilation
Cameron, R. J., de Wit, D., Welsh, T. N., Ferguson, J., Grissell, T. V., & RYE, P. J. (2006) · Intensive Care Medicine · doi:10.1007/s00134-006-0202-x · Cited by 92
Effects of Bacterial Infection on Airway Antimicrobial Peptides and Proteins in COPD
Parameswaran, G. I., Sethi, S., & Murphy, T. F. (2011) · CHEST Journal · doi:10.1378/chest.10-2760 · Cited by 66
Parameswaran, G. I., Wrona, C. T., Murphy, T. F., & Sethi, S. (2009) · BMC Infectious Diseases · doi:10.1186/1471-2334-9-178 · Cited by 64
Peltola, V. T., Heikkinen, T., Ruuskanen, O., Jartti, T. T., Hovi, T., Kilpi, T. M., & Vainionpää, R. (2010) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e318208ee82 · Cited by 63
Experimental rhinovirus infection in volunteers
Pg, B., Sanderson, G., Robinson, B., Holgate, S., & Tyrrell, D. A. J. (1996) · European Respiratory Journal · doi:10.1183/09031936.96.09112250 · Cited by 45
Bacterial Infections Following Experimental Rhinovirus Infection In COPD
Mallia, P., Footitt, J., Trujillo‐Torralbo, M., Oleszkiewicz, G., Omolu, A., Contoli, M., Message, S. D., Papi, A. A., Johnston, S. L., & Kon, O. M. (2011) · doi:10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a3728 · Cited by 2
Self-citationRhinovirus infection induces secondary bacterial infection in COPD
Mallia, P., Footitt, J., Sotero, R., Jepson, A., Oleszkiewicz, G., Aniscenko, J., Kon, O. M., Alberto, P., Johnston, S. L., & Pelaia, G. (2011) · European Respiratory Journal · Cited by 1
Self-citation
Cited by
Antimicrobial host defence peptides: functions and clinical potential
Mookherjee, N., Anderson, M. A., Haagsman, H. P., & Davidson, D. J. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0058-8 · Cited by 1,502
Ritchie, A. I., & Wedzicha, J. A. (2020) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2020.06.007 · Cited by 402
Molyneaux, P. L., Mallia, P., Cox, M. J., Footitt, J., Willis-Owen, S. A. G., Homola, D., Trujillo-Torralbo, M.-B., Elkin, S., Kon, O. M., Cookson, W. O. C., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201302-0341oc · Cited by 390
MacLeod, M., Papi, A., Contoli, M., Beghé, B., Celli, B. R., Wedzicha, J. A., & Fabbri, L. M. (2021) · Respirology · doi:10.1111/resp.14041 · Cited by 359
Self-citationHost–microorganism interactions in lung diseases
Marsland, B. J., & Gollwitzer, E. S. (2014) · Nature Reviews Immunology · doi:10.1038/nri3769 · Cited by 351
Metadata
- Authors
- Mallia, P., Footitt, J., Sotero, R., Jepson, A., Contoli, M., Trujillo-Torralbo, M.-B., Kebadze, T., Aniscenko, J., Oleszkiewicz, G., Gray, K., Message, S. D., Ito, K., Barnes, P. J., Adcock, I. M., Papi, A., Stanciu, L. A., Elkin, S. L., Kon, O. M., Johnson, M., & Johnston, S. L.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-12-01
- Volume
- 186
- Issue
- 11
- Pages
- 1117-1124
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2163139709
- Cited by
- 274
- References
- 34
- FWCI
- 20.63
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.